ID

15915

Description

Combination Chemotherapy With or Without Peripheral Stem Cell Transplant in Treating Children With Acute Lymphoblastic Leukemia; ODM derived from: https://clinicaltrials.gov/show/NCT00022737

Link

https://clinicaltrials.gov/show/NCT00022737

Keywords

Versions (2)
  1. 6/6/16 6/6/16 -
  2. 6/18/16 6/18/16 -
Uploaded on

June 18, 2016

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Childhood Acute Lymphoblastic Leukemia in Remission NCT00022737

English

Eligibility Childhood Acute Lymphoblastic Leukemia in Remission NCT00022737

1 forms  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
diagnosis of acute lymphoblastic leukemia
Description

diagnosis of ALL

Data type

boolean

Alias
UMLS CUI [1,1]
C0011900
UMLS CUI [1,2]
C0023449
received prior front-line therapy on a pediatric oncology group (pog),children's cancer group (ccg), or central oncology group (cog) study
Description

prior front-line therapy on POG, CCG, COG study

Data type

boolean

Alias
UMLS CUI [1,1]
C1514463
UMLS CUI [1,2]
C1518932
received induction therapy comprising vincristine, asparaginase, prednisone/dexamethasone, and daunorubicin as in ccg, pog, or cog protocols
Description

induction therapy

Data type

boolean

Alias
UMLS CUI [1,1]
C3179010
UMLS CUI [1,2]
C0042679
UMLS CUI [2,1]
C3179010
UMLS CUI [2,2]
C0003993
UMLS CUI [3,1]
C3179010
UMLS CUI [3,2]
C0011777
UMLS CUI [4,1]
C3179010
UMLS CUI [4,2]
C3179010
UMLS CUI [5,1]
C3179010
UMLS CUI [5,2]
C0011015
m1 or m2 bone marrow status after front-line induction therapy and presenting with at least 1of the following:
Description

bone marrow status

Data type

boolean

Alias
UMLS CUI [1,1]
C0678852
UMLS CUI [1,2]
C0005953
philadelphia chromosome positive (ph+) with t(9;22)(q34;q11) by cytogenetics or fluorescence in situ hybridization
Description

philadelphia chromosome translocation

Data type

boolean

Alias
UMLS CUI [1]
C0856536
bcr-abl fusion transcript by reverse transcription polymerase chain reaction
Description

bcr-abl fusion

Data type

boolean

Alias
UMLS CUI [1]
C1835417
hypodiploid with less than 44 chromosomes and/or dna index less than0.81
Description

hypodiploid

Data type

boolean

Alias
UMLS CUI [1]
C1835417
UMLS CUI [2]
C2919020
mll translocation (11q23) by cytogenetics and a slow early response (ser) to induction therapy, defined as at least 5% blasts at day 15 of induction and/or at least .1% minimal residual disease (mrd) after induction therapy
Description

mll translocation (11q23)

Data type

boolean

Alias
UMLS CUI [1,1]
C0796367
UMLS CUI [1,2]
C0796367
failed to achieve remission after front-line induction therapy
Description

remission after induction therapy

Data type

boolean

Alias
UMLS CUI [1]
C0687702
m3 bone marrow status (greater than 25% blasts) after induction therapy
Description

m3 bone marrow status

Data type

boolean

Alias
UMLS CUI [1,1]
C0678852
UMLS CUI [1,2]
C0005953
m2 bone marrow status (5-25% blasts) or at least 1% mrd after induction therapy and m2 or m3or at least 1% mrd after consolidation therapy (ccg studies) or extended induction therapy (pog or cog studies)
Description

m2 bone marrow status

Data type

boolean

Alias
UMLS CUI [1,1]
C0678852
UMLS CUI [1,2]
C0005953
see disease characteristics
Description

ID.12

Data type

boolean

not pregnant or nursing
Description

pregnant or nursing

Data type

boolean

Alias
UMLS CUI [1,1]
C0032961
UMLS CUI [1,2]
C0006147
negative pregnancy test
Description

pregnancy test

Data type

boolean

Alias
UMLS CUI [1]
C0032976
fertile patients must use effective contraception
Description

contraception if fertile

Data type

boolean

Alias
UMLS CUI [1]
C0700589
see disease characteristics
Description

ID.16

Data type

boolean

see disease characteristics
Description

ID.17

Data type

boolean

no concurrent prophylactic cranial radiotherapy
Description

concurrent prophylactic cranial radiotherapy

Data type

boolean

Alias
UMLS CUI [1,1]
C1522449
UMLS CUI [1,2]
C3163632
Back to the top of the page

Similar models

Eligibility Childhood Acute Lymphoblastic Leukemia in Remission NCT00022737

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
diagnosis of ALL
Item
diagnosis of acute lymphoblastic leukemia
boolean
C0011900 (UMLS CUI [1,1])
C0023449 (UMLS CUI [1,2])
prior front-line therapy on POG, CCG, COG study
Item
received prior front-line therapy on a pediatric oncology group (pog),children's cancer group (ccg), or central oncology group (cog) study
boolean
C1514463 (UMLS CUI [1,1])
C1518932 (UMLS CUI [1,2])
induction therapy
Item
received induction therapy comprising vincristine, asparaginase, prednisone/dexamethasone, and daunorubicin as in ccg, pog, or cog protocols
boolean
C3179010 (UMLS CUI [1,1])
C0042679 (UMLS CUI [1,2])
C3179010 (UMLS CUI [2,1])
C0003993 (UMLS CUI [2,2])
C3179010 (UMLS CUI [3,1])
C0011777 (UMLS CUI [3,2])
C3179010 (UMLS CUI [4,1])
C3179010 (UMLS CUI [4,2])
C3179010 (UMLS CUI [5,1])
C0011015 (UMLS CUI [5,2])
bone marrow status
Item
m1 or m2 bone marrow status after front-line induction therapy and presenting with at least 1of the following:
boolean
C0678852 (UMLS CUI [1,1])
C0005953 (UMLS CUI [1,2])
philadelphia chromosome translocation
Item
philadelphia chromosome positive (ph+) with t(9;22)(q34;q11) by cytogenetics or fluorescence in situ hybridization
boolean
C0856536 (UMLS CUI [1])
bcr-abl fusion
Item
bcr-abl fusion transcript by reverse transcription polymerase chain reaction
boolean
C1835417 (UMLS CUI [1])
hypodiploid
Item
hypodiploid with less than 44 chromosomes and/or dna index less than0.81
boolean
C1835417 (UMLS CUI [1])
C2919020 (UMLS CUI [2])
mll translocation (11q23)
Item
mll translocation (11q23) by cytogenetics and a slow early response (ser) to induction therapy, defined as at least 5% blasts at day 15 of induction and/or at least .1% minimal residual disease (mrd) after induction therapy
boolean
C0796367 (UMLS CUI [1,1])
C0796367 (UMLS CUI [1,2])
remission after induction therapy
Item
failed to achieve remission after front-line induction therapy
boolean
C0687702 (UMLS CUI [1])
m3 bone marrow status
Item
m3 bone marrow status (greater than 25% blasts) after induction therapy
boolean
C0678852 (UMLS CUI [1,1])
C0005953 (UMLS CUI [1,2])
m2 bone marrow status
Item
m2 bone marrow status (5-25% blasts) or at least 1% mrd after induction therapy and m2 or m3or at least 1% mrd after consolidation therapy (ccg studies) or extended induction therapy (pog or cog studies)
boolean
C0678852 (UMLS CUI [1,1])
C0005953 (UMLS CUI [1,2])
ID.12
Item
see disease characteristics
boolean
pregnant or nursing
Item
not pregnant or nursing
boolean
C0032961 (UMLS CUI [1,1])
C0006147 (UMLS CUI [1,2])
pregnancy test
Item
negative pregnancy test
boolean
C0032976 (UMLS CUI [1])
contraception if fertile
Item
fertile patients must use effective contraception
boolean
C0700589 (UMLS CUI [1])
ID.16
Item
see disease characteristics
boolean
ID.17
Item
see disease characteristics
boolean
concurrent prophylactic cranial radiotherapy
Item
no concurrent prophylactic cranial radiotherapy
boolean
C1522449 (UMLS CUI [1,1])
C3163632 (UMLS CUI [1,2])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial